Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. - Wikidata - awgldk - TriplyDB

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.

http://www.wikidata.org/entity/Q45256250

about

Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications Strategies to characterize fungal lipases for applications in medicine and dairy industry.Lp-PLA2 Antagonizes Left Ventricular Healing After Myocardial Infarction by Impairing the Appearance of Reparative Macrophages Platelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trials Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial The vascular effects of infection in Pediatric Stroke (VIPS) Study.Asymptomatic polyvascular abnormalities in community (APAC) study in China: objectives, design and baseline characteristics.Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells Lp-PLA2 Inhibition-The Atherosclerosis Panacea?Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study.Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Atherosclerotic Cardiovascular Risk in Japan.Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.Racial variation in lipoprotein-associated phospholipase A₂ in older adults.Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice.High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke.Why does a high-fat diet induce preeclampsia-like symptoms in pregnant rats.Circulating and PBMC Lp-PLA2 associate differently with oxidative stress and subclinical inflammation in nonobese women (menopausal status).Blood biomarkers in cardioembolic stroke.Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.Taiwanese female vegetarians have lower lipoprotein-associated phospholipase A2 compared with omnivores.China suboptimal health cohort study: rationale, design and baseline characteristics.Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women.Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.Inflammatory biomarkers of vascular risk as correlates of leukoariosis.The association among lipoprotein-associated phospholipase A2 levels, total antioxidant capacity and arousal in male patients with OSA.Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases.Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques The Rotterdam Study: 2012 objectives and design update.STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A2 (Lp-PLA2) as a biomarker or risk factor for cardiovascular diseases.Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis Blood biomarkers of ischemic stroke.

P2860

Q26777871-327D86B3-2BC0-4548-BB5A-E9FD4E25033D Q26822831-011E9D09-54D2-4715-BC1E-839AFFD9A87C Q28388609-92415005-9781-446F-A03A-F463EB1403D6 Q28539153-90C1EABF-FD6F-4436-A062-B0E8A2A937E5 Q28539991-C99E4DE8-395F-4BDA-AFC9-8BBBEA1AAF2B Q30425204-1404B70B-60AD-4BBB-9735-5048E07A0475 Q30444936-188D9376-85C8-462A-A90E-D1E8E44669EA Q31100823-FCC9E898-FEF6-468E-8A4F-7B9C566B43DC Q33536648-BC15C70D-EC81-4DA6-BFDB-AD40D894ADAF Q33593900-F714D272-FA7E-423E-BCEF-BDCE92BF3739 Q33664272-1472C8B7-52A4-4C6B-BF9F-7FCFB391359A Q33666216-2BA77FD3-4D05-447A-9E7F-D0BEBEC38995 Q33755952-5F555D06-39C6-404A-859F-4F5B8237D323 Q33756465-FE5FA58F-B497-473A-BD3E-A8B04E060A9B Q33803486-FF7AB149-D3EC-43FD-B1B8-82971E0686F2 Q33805731-4C39F469-A491-47CE-94DF-95CCF56EA4EC Q33825407-00244111-CE14-46BB-BF21-DF859274AC9B Q33849524-D9A671B2-6C9B-4767-9AEF-CAF8FDB9394A Q33895897-74B6A195-165B-46F7-B9CD-16F7C4B8564D Q33944562-8DEB949A-C966-467C-8EBC-A8B7A434859B Q33946023-DCE2EA39-9875-4CAF-9BA8-913B9C77F75C Q34016317-BC120891-836C-4CF2-8804-6C13A65B8610 Q34036010-456AC211-E625-450E-BD36-6EA5747DAC80 Q34094810-2A77293E-D4DD-4948-A17B-03050399B446 Q34167997-3CE5DC52-0A09-49CF-BBB3-CC7D147C61C8 Q34362880-35620A1E-A0CA-4E8E-A9DB-CC15FADBAE38 Q34413793-E56F07C6-24FF-4ACC-AD2F-697FCC91D8E3 Q34474519-0C3E77D3-1A82-4556-9D6F-65C82D35C03C Q34542566-318B0778-3B38-4CB3-95D5-FB7117D20E97 Q34776755-355AA7D5-5487-4E51-B44D-290C1DD2E937 Q34987055-4128877C-9BC4-4191-9E88-7D1F03701EC7 Q35045118-C75FDA0B-6CC6-45D5-8260-A38463AD41B0 Q35057921-916F4380-2C93-4FBD-B2BE-89F3E539521B Q35146962-6955CA8D-2D59-4055-B776-7B2ACE705C7D Q35180144-6940C350-7794-4527-BD8E-56848B566980 Q35201574-A558C068-1761-471B-9C57-7696B999A665 Q35217973-19262C3A-29B7-4551-964B-668F6981356F Q35267751-93E2842D-44FB-4B32-A1E4-334F55A32D65 Q35556624-2EAD9D98-B673-4972-8B5A-231832CFCAF1 Q35648087-810C92C2-25E3-42A2-8E49-387A4CC52A42

P2860

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.

http://www.wikidata.org/entity/Q45256250

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@en

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@nl

type

label

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@en

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@nl

prefLabel

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@en

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@nl

P1433

Q45256250-E203EA1F-8F1C-40BC-9711-E9D10438F809

P1476

Q45256250-C094EB3E-92C9-43A3-BD91-02586F777A51

P2093

Q45256250-10F30B59-11CB-4E14-A913-3E5A0BF6E414

Q45256250-26B19CC8-D648-4A95-BF77-9950AFB9825A

Q45256250-2A351F73-3171-4BCA-A6A5-2C3DF1C5F4C1

Q45256250-8BA4F447-7935-4B6A-A194-897488151239

Q45256250-BD538E18-C851-4AA4-A2EB-EEF0158770CC

Q45256250-D909448C-508F-45E8-A643-16A26B3AB8D4

P304

Q45256250-410119CA-B83B-40B3-862B-6A533B76590E

P31

Q45256250-83032369-FA16-497B-BF5B-4ED64FAAE907

P356

Q45256250-6EE708F6-4770-4C25-8313-B646AEFA1A89

P407

Q45256250-9750FA77-1CF4-45C6-B328-085049C19423

P433

Q45256250-B7CA8E80-5F4D-4422-AB32-72C9ADCCD4BB

P478

Q45256250-9474D3ED-81FC-4602-8E58-C5995BE592ED

P50

Q45256250-DC1595FC-1B8C-4D72-8C92-0DAB9620A535

P577

Q45256250-8627251F-3753-45A6-B2AA-D2CED1F2ADD1

P698

Q45256250-19863898-4117-422E-968C-5EF6975C566F

P921

Q45256250-F0490297-E4EF-4CF0-ABDF-3F20ECAFA998

P356

01.CIR.0000154553.12214.CD

P1433

P1476

Lipoprotein-associated phospho ...... c stroke: the Rotterdam Study.

@en

P2093

Hok-Hay S Oei

http://www.w3.org/2001/XMLSchema#string

Irene M van der Meer

http://www.w3.org/2001/XMLSchema#string

Jacqueline C M Witteman

http://www.w3.org/2001/XMLSchema#string

Monique M B Breteler

http://www.w3.org/2001/XMLSchema#string

Peter J Koudstaal

http://www.w3.org/2001/XMLSchema#string

Theo Stijnen

http://www.w3.org/2001/XMLSchema#string

P304

570-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000154553.12214.CD

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15699277

http://www.w3.org/2001/XMLSchema#string

P921